共 50 条
- [42] Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in higher-grade meningiomas JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2022, 81 (06): : 469 - 470
- [45] MTAP and p16 Immunohistochemistry as Markers for CDKN2A/B Loss in Meningiomas JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (06): : 546 - 546
- [47] Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas Virchows Archiv, 2008, 453 : 627 - 635
- [48] THE VALUE OF BAP1 IMMUNOCYTOCHEMISTRY AND CDKN2A FLUORESCENCE IN SITU HYBRIDIZATION IN DIAGNOSIS OF SEROUS EFFUSION MALIGNANT MESOTHELIOMA AND AN ANALYSIS OF THE ASSOCIATION BETWEEN DEGREE OF CELL ATYPIA AND THE RESULTS OF TWO AUXILIARY METHODS POLISH JOURNAL OF PATHOLOGY, 2020, 71 (03) : 229 - 235